Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Palisade Bio	PALI	18. nov 2024	2.39	-5.16
Palladyne AI	PDYN	18. nov 2024	1.78	-3.78
Palmer Square Capital BDC	PSBD	18. nov 2024	15.62	-0.95
Palo Alto Networks	PANW	18. nov 2024	386.83	-0.04
Palomar Holdings	PLMR	18. nov 2024	108.48	+4.62
Paltalk	PALT	18. nov 2024	1.90	+3.83
Pampa Energia ADR	PAM	18. nov 2024	80.02	+4.77
Pan American Silver	PAAS	18. nov 2024	22.70	+6.03
Pangaea	PANL	18. nov 2024	6.05	-3.97
Papa Johns International	PZZA	18. nov 2024	47.85	+1.12
Papaya Growth Opportunity I SPAC A	PPYA	18. nov 2024	11.13	0.00
Papaya Growth Opportunity I Unit	PPYAU	18. nov 2024	11.19	0.00
Par Pacific	PARR	18. nov 2024	17.79	+0.79
PAR Technology	PAR	18. nov 2024	71.67	-0.90
Paragon 28	FNA	18. nov 2024	10.20	+1.90
Paramount Global A	PARAA	18. nov 2024	22.15	-0.85
Paramount Global B	PARA	18. nov 2024	10.61	-2.12
Paramount Gold Nevada	PZG	18. nov 2024	0.41	-10.64
Paramount Group	PGRE	18. nov 2024	4.70	-2.49
Paranovus Entertainment Technology A	PAVS	18. nov 2024	0.95	+3.26
ParaZero Technologies	PRZO	18. nov 2024	0.59	-0.32
Park Aerospace	PKE	18. nov 2024	14.66	-0.34
Park Hotels & Resorts	PK	18. nov 2024	14.28	-1.45
Park National	PRK	18. nov 2024	190.52	-1.05
Park-Ohio	PKOH	18. nov 2024	31.93	-0.81
Parke Bancorp	PKBK	18. nov 2024	22.95	+0.04
Parker-Hannifin	PH	18. nov 2024	691.68	-1.03
Parsons	PSN	18. nov 2024	94.37	-3.11
Pasithea Therapeutics	KTTA	18. nov 2024	3.20	-5.33
Passage Bio	PASG	18. nov 2024	0.47	-9.25

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.